Fate therapeutics shareholder class action investigation: submit your losses to johnson fistel

Fate class action investigation has commenced on behalf of shareholderssan diego, california--(newsfile corp. - january 21, 2023) - shareholder rights law firm johnson fistel, llp is investigating whether fate therapeutics, inc. (nasdaq: fate) ("fate" or the "company), any of its executive officers, or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. the investigation focuses on investors' losses and whether they may be recovered under federal securities laws.
FATE Ratings Summary
FATE Quant Ranking